2, 13-disubstituted ergolines, their production and use in
申请人:Schering Aktiengesellschaft
公开号:US05411966A1
公开(公告)日:1995-05-02
Compounds of formula I and their acid addition salts ##STR1## in which R.sup.2 R.sup.6 R.sup.13 and X have the meanings defined herein are described as well as a process and intermediates for their production, and pharmaceutical agents containing these compounds.